Céline Alloux

Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2020 · 174 citations

Medicine, Oncology, Pharmacology +16

High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure

Lila Bouadma, Armand Mekontso Dessap, Charles Burdet et al. · JAMA Internal Medicine · 2022 · 148 citations · Full text

Medicine, Pharmacotherapy, Critical Care Pharmacotherapy +16

Hypersensitivity to oxaliplatin: clinical features and risk factors

Marie Parel, Florence Ranchon, Audrey Nosbaum et al. · BMC Pharmacology and Toxicology · 2014 · 104 citations · Full text

Medicine, Oncology, Pharmacology +15

EPICC study: evaluation of pharmaceutical intervention in cancer care

Nicolas Vantard, Florence Ranchon, Vérane Schwiertz et al. · Journal of Clinical Pharmacy and Therapeutics · 2015 · 36 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +17

Pembrolizumab as first line therapy in patients with unresectable squamous cell carcinoma of the skin: Interim results of the phase 2 CARSKIN trial.

E. Maubec, Marouane Boubaya, Peter Petrow et al. · Journal of Clinical Oncology · 2018 · 24 citations

Medicine, Oncology, Pharmacology +17